eFFECTOR Therapeutics Inc. Gains 37.62%

Tue, Jun 06, 2023 at 07:42 PM
eFFECTOR Therapeutics Inc. Gains 37.62%

eFFECTOR Therapeutics Inc. (EFTR:NASDAQ) rocketted at $1.39, representing a gain of 37.6%. On Tue, Jun 06, 2023, EFTR:NASDAQ touched a New 2-Week High of $1.39. The stock appeared on our News Catalysts scanner on Thu, May 25, 2023 at 06:17 PM in the 'BIOTECH' category. From Tue, May 23, 2023, the stock recorded 77.78% Up Days and 60.00% Green Days

About eFFECTOR Therapeutics Inc. (EFTR:NASDAQ)

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.